GSK – Startup Investor Profile

GSK is a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.

Location: Kelayres

Country:

Investment Regions:

Investment Stages: late-stage

Website: http://www.gsk.com/

AI Reasoning: I found a GSK press release showing GSK agreed to acquire IDRx, Inc. on 13 January 2025. This is an investment/acquisition activity involving the startup IDRx. From 13 January 2025 to the reference date is less than 10 months; specifically, it is within the last year and within 3 months? Wait: Calculate: Jan 13 to Nov 1 is ~9.6 months, which is between 12 and 6 months – that would map to low-active. However, also found acquisition news May 14, 2025 regarding efimosfermin (Biospace) and earlier acquisitions in 2024 and Dec 5, 2024 deal with Muna Therapeutics. The May 14, 2025 item indicates activity within less than 6 months (from May 14 to Nov 1 ~5.5 months), which places the last known investment between 6 and 3 months ago, classifying as active. The most recent confirmed investment/acquisition found is May 14, 2025 (efimosfermin acquisition), involving a company named efimosfermin. Therefore the correct tag is “active”.

Not Active – No known investments in the last 12 months.

Low Activity – Only known investments between the last 12 and 6 months.

Active – Known investments between the last 6 and 3 months.

Very Active – Known investments in the last 3 months.